Cancer Prevention Drug Being Developed By NCI
- MedicalNewsToday, 15 May
While researching new ways to stop the progression of cancer, researchers at the University of Oklahoma Health Sciences Center, have discovered a compound that has been shown to prevent cancer in the laboratory. The research appears in the journal Gene Regulation and Systems Biology. Original report
|
 |
Scientists Unravel How Smoking Causes Cancer
- MedicalNewsToday, 15 May
Scientists have for the first time pinpointed a protein that explains how smoking can directly lead to genetic changes that cause cancer - research published in the British Journal of Cancer reveals.
Original report
|
 |
Architecture For Fundamental Processes Of Life Discovered By Researchers
- MedicalNewsToday, 15 May
A team of Canadian researchers has completed a massive survey of the network of protein complexes that orchestrate the fundamental processes of life. In the online edition of the journal Science, researchers from the Universite de Montreal describe protein complexes and networks of complexes never before observed - including two implicated in the normal mechanisms by which cells divide and proliferate and another that controls recycling of the molecular building blocks of life called autophagy. Original report
|
 |
Procedure May Reduce Hot Flushes For Breast Cancer Survivors
- MedicalNewsToday, 15 May
A stellate-ganglion block is a numbing of the star-shaped collection of nerves in the neck that is thought to affect both temperature and sleep control. A new study published in The Lancet Oncology reports that breast cancer survivors who are treated with a stellate-ganglion block can achieve long-term relief from hot flushes and sleep problems. Original report |
|
GPs' failure to spot cancer raising death rates
- Telegraph.co.uk, 14 April
Patients are dying because their doctors are failing to detect that they have cancer, the Government's leading expert on the disease has warned. Original report
|
|
Trans-fats linked to breast cancer
- News-Medical.Net, 14 April
Trans fats are currently being phased out of food in many countries because they clog arteries and increase the risk of heart disease. Original report |
 |
Drug Protects Cells From Radiation
- Medical News Today, 14 April
A drug that protects healthy cells from radiation as been found, The Guardian reports. The drug "could improve the effectiveness of radiation therapy in treating cancer and help prevent radiation sickness after exposure to a nuclear accident or attack," the newspaper adds. Original report |
|
Researchers Find That Targeted Therapy Combination Overcomes Treatment Resistance In Liver Cancer
- Medical News Today, 14 April
Researchers at the University of Pennsylvania School of Medicine and Abramson Cancer Center reported at the annual meeting of the American Association for Cancer Research that combining two targeted therapies overcomes treatment resistance in liver cancer cell lines. The team is currently designing a trial to test the combination in patients.Original report |
|
Vitamin K2 linked to lower prostate cancer risk
- Nutraingredients.com, 9 April
An increased intake of vitamin K2 may reduce the risk of prostate cancer by 35 per cent, suggest results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Original report
|
 |
Phase II Study of IMC-A12 for Advanced Head and Neck Cancer Commences Patient Enrollment
- PharmaLive, 9 April
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that a Phase II clinical trial of its anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody IMC-A12 in patients with head and neck cancer has commenced patient enrollment. Original report |
|
High-Intensity Chemotherapy Does Not Improve Survival In Small Cell Lung Cancer
- Medical News Today, 9 April
Small cell lung cancer (SCLC) patients treated with high-dose chemotherapy did not have better survival rates than those treated with standard doses, according to a randomized controlled trial published online April 8 in the Journal of the National Cancer Institute. Original report |
 |
Stopping A Cancer Trial Early: Is It For The Benefit Of Patients Or Industry?
- Medical News Today, 9 April
New research has identified a growing trend for trials of new cancer treatments to be stopped prematurely before the therapies' risks and benefits have been properly evaluated.
In a study, published online today (Wednesday 9 April) in the cancer journal, Annals of Oncology [1], Italian researchers analysed 25 randomised controlled clinical trials that had been stopped early because they had started to show a benefit to patients and found that the numbers had increased dramatically in recent years. They warn that this could lead to a systematic over-statement of the effects of treatment, and that patients could be harmed by new therapies being rushed prematurely into the clinic. Original report |
 |
- Boston.com, 20 March
|
|
- The Wall Street Journal, 20 March
|
|
- Forbes, 20 March
|
|
- Medical News Today, 20 March
|
|
- Nursing in Practice, 3 March
|
|
- The Boston Globe, 3 March |
|
- The Scotsman, 3 March
|
|
- News-Medical.Net, 3 March
|
 |
- Medical News Today, 25 February
|
|
- The Birmingham News, 25 February
|
|
- FoodConsumer.org, 24 February
|
 |
- CNN Money, 24 February
|
|
- Fox Business, 20 February
|
|
- The Wall Street Journal, 20 February
|
|
- U.S. News, 20 February
|
|
- Science Daily, 19 February
|
|
- The Indiabapolis Star, 12 February
|
|
- The Age, 11 February
|
|
- Science Daily, 11 February
|
|
- The Washington Post, 11 February
|
|
|
